ABBV vs SLRX

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

SLRX (Salarius Pharmaceuticals, Inc.) was acquired by VolitionRx Limited (VNRX) on October 18, 2023, and subsequently delisted. As of today, 2026-03-29, it does not exist as an independent publicly traded entity with any growth prospects. The quoted current price of $7.62 is an anomaly for a delisted ticker and does not reflect a liquid, investable asset. There have been no material changes since ...